(Q51663001)

9 April 2018

title

The design of probiotic studies to substantiate health claims. (English)

1 reference

9 April 2018

0 references

3

Erika Isolauri

1 reference

9 April 2018

Catherine Stanton

9

object named as

Catherine Stanton

1 reference

9 April 2018

author name string

Glenn R Gibson

1

1 reference

9 April 2018

Robert J Brummer

2

1 reference

9 April 2018

Herbert Lochs

4

1 reference

9 April 2018

Lorenzo Morelli

5

1 reference

9 April 2018

Theo Ockhuizen

6

1 reference

9 April 2018

Ian R Rowland

7

1 reference

9 April 2018

Jürgen Schrezenmeir

8

1 reference

9 April 2018

Kristin Verbeke

10

1 reference

9 April 2018

publication date

1 September 2011

1 reference

9 April 2018

published in

Gut microbes

1 reference

9 April 2018

volume

2

1 reference

9 April 2018

issue

5

1 reference

9 April 2018

page(s)

299-305

1 reference

9 April 2018

What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?

cites work

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Mechanisms of action of probiotics in intestinal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Probiotics-host communication: Modulation of signaling pathways in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Probiotic and prebiotic claims in Europe: seeking a clear roadmap

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Health claims substantiation for probiotic and prebiotic products.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Guidance on the scientific requirements for health claims related to gut and immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health?

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Probiotics: a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Probiotics for prevention of antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

News from the Cochrane Library: probiotics for the prevention of paediatric antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Selection of methodology to assess food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Bias in dietary-report instruments and its implications for nutritional epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21).

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Stool form scale as a useful guide to intestinal transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

An Irritable Bowel Syndrome-Specific Symptom Questionnaire: Development and Validation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Validation of a specific quality of life questionnaire for functional digestive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Meta-analysis of probiotics for the prevention of traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Scientific Opinion on the substantiation of a health claim related Immunofortis® and strengthening of the baby's immune system pursuant to Article 14 of Regulation (EC) No 1924/2006

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FGMIC.2.5.18002

21 January 2018

Identifiers

DOI

10.4161/GMIC.2.5.18002

1 reference

9 April 2018

PubMed ID

22067941

1 reference

9 April 2018